ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
140.22
+6.26 (4.67%)
At close: May 12, 2025, 4:00 PM
139.92
-0.30 (-0.21%)
After-hours: May 12, 2025, 5:02 PM EDT
ICLR Revenue
ICON Public Limited Company had revenue of $2.00B in the quarter ending March 31, 2025, a decrease of -4.26%. This brings the company's revenue in the last twelve months to $8.19B, down -0.48% year-over-year. In the year 2024, ICON Public Limited Company had annual revenue of $8.28B with 1.99% growth.
Revenue (ttm)
$8.19B
Revenue Growth
-0.48%
P/S Ratio
1.34
Revenue / Employee
$195,528
Employees
41,900
Market Cap
11.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.28B | 161.50M | 1.99% |
Dec 31, 2023 | 8.12B | 378.79M | 4.89% |
Dec 31, 2022 | 7.74B | 2.26B | 41.24% |
Dec 31, 2021 | 5.48B | 2.68B | 95.93% |
Dec 31, 2020 | 2.80B | -8.55M | -0.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ICLR News
- 5 days ago - Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies - Business Wire
- 10 days ago - ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - ICON Reports First Quarter 2025 Results - Business Wire
- 4 weeks ago - GreensKeeper Q1 2025 Portfolio Update - Seeking Alpha
- 5 weeks ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ICON - Accesswire
- 6 weeks ago - ICON plc Schedules First Quarter 2025 Earnings Conference Call - Business Wire
- 7 weeks ago - BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR) - PRNewsWire
- 7 weeks ago - ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review - Business Wire